We evaluated the functional and oncological outcomes of transoral laser microsurgery (TLM) in patients with previously untreated supraglottic carcinoma compared with the outcomes in salvage cases after radiation-based treatment.
INTRODUCTION
Surgery and radiotherapy are the primary treatment options for definitive management of supraglottic carcinoma. Historically, conventional open surgery has provided oncological outcomes and laryngeal preservation rates comparable to those of radiotherapy-based regimens. [1] [2] [3] Conventional open supraglottic laryngectomy, however, is associated with high rates of aspiration in the acute postoperative setting and requires temporary tracheostomy in most cases. 4, 5 Adjuvant radiotherapy after open supraglottic laryngectomy has been shown to further compound postoperative functional problems. 6 In addition, nonsurgical laryngeal preservation regimens combining radiation and chemotherapy commonly result in dysphagia; current evidence suggests that chronic aspiration is a late consequence of these treatments in up to 40% of patients. [7] [8] [9] Transoral laser microsurgery (TLM) has become widely accepted as a minimally invasive surgical alternative for management of supraglottic carcinoma. It demonstrates oncological outcomes comparable to those of radiotherapy-based regimens and conventional open techniques. [10] [11] [12] Moreover, several advantages of TLM relative to open supraglottic laryngectomy appear in the literature, including faster recovery of swallowing function, a lower incidence of aspiration pneumonia, lower rates of tracheostomy, and shorter hospital stays. 10, [13] [14] [15] [16] [17] Transoral laser microsurgery also plays a role in the salvage setting, as an alternative to total laryngectomy, with satisfactory oncological results reported for select patients after previous irradiation. 18 Although previous authors have demonstrated broad applications of TLM with functional advantages over conventional open surgery, comparative studies of functional outcomes in primary and salvage settings are lacking. We conducted a retrospective case-control review for the purpose of comparing functional and oncological outcomes of TLM in the primary and salvage settings.
MATERIALS AND METHODS
We conducted a retrospective case-control review at a single academic tertiary care institution. Ten patients who underwent TLM for supraglottic laryngeal carcinoma between January 2004 and September 2009 were included. All patients with histologically proven carcinoma of the supraglottic larynx treated with TLM in the primary or salvage setting were eligible. Patients with tumor involvement of the vocal cords and those with hypopharyngeal carcinoma that extended to the supraglottis were excluded. Outcomes were stratified by previous radiation exposure. Disease characteristics, rates of disease control, and final level of feeding tube dependence were evaluated by medical chart review. Follow-up data were available for all patients.
Preoperative Assessment. All patients underwent staging endoscopy, laryngeal videostroboscopy, and computed tomographic (CT) imaging of the pharynx, larynx, esophagus, oral cavity, and cervical lymph nodes to permit detailed assessment of the tumor and to rule out synchronous primaries. Tumor classification was conducted according to the American Joint Committee for Cancer staging, 2002 version. 19 Operative Technique. The operative procedures were performed under general anesthesia with orotracheal intubation. A Lindholm or distending Steiner laryngoscope was used to visualize the supraglottic larynx. All patients had TLM tumor resection comparable to standard open supraglottic resection, including the epiglottis, the false vocal folds, and the preepiglottic fat, but sparing the thyroid cartilage. A carbon dioxide laser was coupled with an operating microscope, allowing precise coaxial delivery of both the aiming beam and the carbon dioxide cutting beam to the operative field. The initial incision was made with the carbon dioxide laser along the median glossoepiglottal fold to split the epiglottis in the sagittal plane. The hyoid bone and the preepiglottic space were visualized carefully, with layerby-layer dissection. The preepiglottic space was first surveyed. Gross infiltration of the preepiglottic space can be seen under a microscope, whereas microscopic invasion is detectable only by histopathologic evaluation of the resected specimen. The extent of preepiglottic excision was, therefore, considered on the basis of the frozen section results. In case of tumor extension to the paraglottic space, the tumor was followed and parts of the vocalis muscle were resected. The resected specimens were histopathologically examined. If histopathologic analysis showed a positive resection margin, additional resection was carried out to obtain clear margins.
Elective neck dissection was recommended for all previously untreated patients with clinically negative nodal (N0) disease. The possibilities of occult nodal metastasis, including the risks, benefits, and alternatives of surgical management, were thoroughly discussed with all patients. If elective neck dissection was declined, the patient's neck was followed closely with a "watch and wait" policy. This included careful physical examination, as well as routine Doppler ultrasonography or CT scanning every 8 to 12 weeks. Fine-needle aspiration was performed in case of a suspected node. The a priori criteria for adjuvant radiotherapy or chemoradiation included the presence of at least 1 of the following features: a positive tumor margin, perineural invasion, tumor embolus, extracapsular extension, or more than 1 positive lymph node.
Functional Assessment. Modified barium swallow (MBS) study results and the Performance Status Scale-Head and Neck 20 (PSS-HN) were uniformly collected in institutional databases. The MBS studies were conducted by standard methods described previously. 21 Varibar thin liquid barium was administered to all subjects; additional thickened liquid consistencies and solids were administered at the discretion of the treating clinician. Compensatory swallowing strategies were selected and attempted at the discretion of the treating clinician on the basis of the swallowing deficits observed during the study. The MBS study results included the presence or absence of aspiration (sensate or silent), silent laryngeal penetration, the effectiveness of compensatory swallowing strategies, and the recommendations of the MBS study. Tracheostomy and feeding tube status were recorded at the time of the MBS study. The PSS-HN was administered by the speech pathologist at the time of the MBS study. All patients had at least 1 postoperative MBS study. The results of fiberoptic endoscopic evaluation of swallowing and/or clinical swallow evaluations were recorded by medical chart review for subjects who did not receive an MBS study during the assessment period. Diet levels were recorded with the PSS-HN Normalcy of Diet subscale, in which 0 indicates non-oral nutrition and 100 represents full oral nutrition without restrictions. Speech intelligibility was measured with the PSS-HN Understandability of Speech subscale, in which 0 indicates "never understandable" speech and 100 represents "always understandable" speech. The PSS-HN scores for these two subscales are described in Table 1 . 20 Speech and swallowing outcomes were analyzed at 3 assessment periods: 1) before operation; 2) in the immediate postoperative period (less than 1 week after surgery); and 3) in the final (at least 1 month after surgery) postoperative period. The study was approved by the Institutional Review Board at The University of Texas M. D. Anderson Cancer Center. A waiver of informed consent was obtained.
Statistical Methods. Descriptive statistics were calculated to summarize sample characteristics and functional and oncological outcomes. Statistical associations between groups for categorical variables were analyzed with Fisher's exact test. Statistical differences between groups for continuous variables were analyzed with Wilcoxon's rank sum test. Statistical significance was defined as an α level of 0.05. Statistical analyses were performed with STATA data analysis statistical software, version 10.0 (StataCorp LP, College Station, Texas).
RESULTS
Population and Oncological Outcomes. Ten patients (8 male, 2 female) who underwent TLM for supraglottic carcinoma were included. Five patients underwent TLM for stage I to III (T1-3 N0 M0) previously untreated disease, and 5 previously irradiated patients underwent salvage TLM for local fail-ure. Of the salvage cases, 2 had prior chemoradiation and 3 had radiation therapy alone. Nine of the 10 patients had a diagnosis of squamous cell carcinoma, and 1 patient with T3 N0 disease had a diagnosis of adenoid cystic carcinoma of the epiglottis.
All patients had adequate tumor visualization and satisfactory resections without positive tumor margins. No patient required tracheostomy. No surgical complications occurred. At a median follow-up of 38 months (range, 26 to 60 months), there was no recurrence (local or regional) for any patient who underwent TLM as primary therapy (local control rate, 100%); furthermore, none required adjuvant radiotherapy. One of the 5 salvage patients developed recurrence at the primary site and was initially salvaged with repeat TLM, but ultimately died of local recurrence at 27 months. At a median followup of 28 months (range, 10 to 52 months), the local control rate for the previously irradiated patients was 80%. The laryngeal preservation rates were 100% in both groups. The rates of overall survival were 100% in the previously untreated group and 60% in the salvage group. One salvage patient died of local recurrence 27 months after TLM after refusing salvage total laryngectomy, and the other died of adenocarcinoma of the liver 10 months after TLM. The population characteristics and oncological outcomes are summarized in Table 2 .
During the follow-up period, 1 patient in the previously untreated group developed an ipsilateral level IIa neck node that was confirmed by ultrasound and CT scan 15 weeks after TLM. Fine-needle aspiration cytologically confirmed metastatic disease. Subsequent neck dissection of levels II to IV revealed 1 of 20 lymph nodes to be positive for metastasis without extracapsular spread or lymphovascular invasion on pathologic examination.
Baseline Functional Status. The baseline functional outcomes for both groups are tabulated in Table 3. All patients received a baseline MBS study. Neither aspiration nor silent laryngeal penetration was identified at baseline in the previously untreated patient group. In contrast, the baseline MBS studies documented impaired airway protection in 4 of the 5 salvage patients; 3 of these patients demonstrated trace, silent aspiration responsive to swallowing strategies, and 1 demonstrated silent laryngeal penetration. No patient in either group was gastrostomyor tracheostomy-dependent at baseline. All patients ate a soft or regular diet without liquid restrictions at baseline, and 4 of the 5 patients in each group had an unrestricted diet per PSS-HN scores (Normalcy of Diet score of 100) at baseline.
All previously untreated patients were rated as "always understandable" (PSS-HN Understandability of Speech score of 100) at baseline. Four of the 5 salvage patients were rated at baseline as "always understandable" (score of 100), and 1 was rated "usually understandable" (score of 75).
Immediate Postoperative Swallowing Outcomes. The functional status and diet recommendations from the first postoperative week are outlined in Table 4 . Modified barium swallow studies were conducted in 4 of the 5, and fiberoptic endoscopic evaluation of swallowing in 1 of the 5, previously untreated patients in the immediate postoperative period (median, 2 days after operation; range, 1 to 6 days). Sensate aspiration was documented in 3 of the 5 previously untreated patients (60%), whereas 2 patients who had false vocal fold primaries did not aspirate in the first postoperative week. Three patients began a regular diet with thin liquid (with or without strategies), and nothing-by-mouth status was recommended for only 1 previously untreated patient in the first postoperative week. Although 3 of the 5 previously untreated patients (60%) required a feeding tube in the first postoperative week, 1 tube was removed after 2 days because the MBS study found mild aspiration responsive to swallowing strategies.
In the immediate postoperative period (less than 1 week), 3 of the 5 salvage patients underwent an MBS study, and the remaining 2 were assessed with a clinical swallow evaluation only (median, 3 days after operation; range, 1 to 7 days). Instrumental evaluation was postponed in these 2 patients because of the severity of aspiration symptoms on bedside examination in 1 and the ability to alleviate aspiration symptoms at bedside in the other. All 5 salvage patients aspirated in the immediate postoperative period; silent aspiration was documented in 2 of these patients (40%). Two of the 5 (40%) remained without oral intake in the immediate postoperative period because of significant aspiration. A total of 3 of the 5 salvage patients were feeding tube-dependent in the first postoperative week.
Final Postoperative Swallowing Evaluation. In the final assessment period (more than 1 month after surgery), aspiration was significantly more common in the salvage patients than in the previously untreated patients (p = 0.048). Four of the 5 salvage patients underwent MBS studies in this assessment period, and the remaining patient, who demonstrated mild aspiration responsive to strategies on MBS study in the immediate postoperative period, was assessed with a clinical swallow evaluation only (median, 7 weeks; range, 4 to 59 weeks). All 5 salvage patients continued to aspirate during swallowing evaluations in the final postoperative period; silent aspiration was documented in 2 of these patients (40%). Four of the 5 salvage patients tolerated oral intake despite aspiration, but all 4 required the use of compensatory swallowing strategies to prevent aspiration. Only 1 of the 5 (20%) remained without oral intake in the final postoperative period.
Four of the 5 patients in the previously untreated group underwent MBS studies in the final postoperative period (median, 17 weeks; range, 9 to 206 weeks), and 1 patient, whose MBS study findings in the immediate postoperative period were normal, did not return for repeat MBS study in the final period. Silent aspiration, responsive to swallowing strategies, was documented in only 1 of the 5 previously untreated patients (20%) at last assessment, and this patient subsequently reported tolerating a regular, unrestricted diet at the 6-and 24-month follow-up visits. At the time of last assessment, all previously untreated patients ate a regular oral diet without restrictions.
Postoperative Speech Outcomes. The PSS-HN Understandability of Speech scores were captured for all patients in the postoperative setting. The median postoperative PSS-HN Understandability of Speech scores were 75 ("usually understandable") in the salvage group and 100 ("always understandable") in the previously untreated group.
Feeding Tube Dependency. Overall, 6 of the 10 (60%) patients required a feeding tube after operation: 3 of the 5 in the salvage group and 3 of the 5 in the previously untreated group. All 5 patients with epiglottic tumors required a feeding tube, whereas 1 of the 5 patients with false vocal fold tumors required a feeding tube (p = 0.048). The duration of feeding tube dependence was significantly longer in the salvage patients than in the previously untreated patients (p = 0.049). Among the 3 salvage patients who required gastrostomy, all remained tube-dependent more than 1 year after surgery. Two of these 3 salvage patients were slowly weaned off tube feedings (413 and 724 days), and 1 remained tube-dependent at last follow-up (1,077 days). Both salvage patients with epiglottic tumors were tube-dependent for 2 years or more. All previously untreated patients with epiglottic tumors (3 of 5) required a feeding tube after operation; the tubes were subsequently removed, 2, 24, and 181 days after operation. Neither of the previously untreated patients with false vocal fold primaries (2 of 5) required a feeding tube, and no previously untreated patient remained tubedependent at last follow-up. The overall functional outcomes (baseline and final) are summarized in Table 3 .
DISCUSSION
Transoral laser microsurgery has evolved as an important minimally invasive surgical option for management of supraglottic carcinoma. Satisfactory oncological results have been achieved in patients with early T1 and T2 disease and in selected T3 cases, but also in cases of salvage resection after radiation failure. [10] [11] [12] 18, 22 Local control and laryngeal preservation rates above 85% are commonly reported in patients with previously untreated supraglottic disease, 10, 22 and 88% 2-year locoregional control was achieved in patients with recurrent supraglottic carcinoma treated with salvage TLM in a single multicenter case series. 18 Our outcomes compare favorably with these reports, as the local control rate was 90% overall. We observed only 1 local failure, which was amenable to salvage total laryngectomy; this patient was in the previously irradiated group.
Radiotherapy may impart a number of soft-tissue side effects commonly resulting in dysphagia and aspiration in individuals treated for supraglottic carcinomas. 7, 9 The potential to avoid radiotherapy is a particularly attractive feature of the use of TLM for primary treatment of supraglottic carcinoma. In our study, all previously untreated patients who underwent supraglottic TLM were treated with a single modality and avoided adjuvant radiotherapy. It is, therefore, not surprising that both early and final functional outcomes were clearly superior in previously untreated patients. In fact, all 5 salvage TLM patients continued to aspirate on final swallow studies, as compared to only 1 of 5 previously untreated patients. These data suggest that chronic aspiration is to be expected after salvage supraglottic TLM. It is noteworthy that despite chronic aspiration, most salvage patients slowly resumed oral intake after operation and that only 1 remained gastrostomy-dependent at last follow-up. These data suggest a po-tential for recovery of functional swallowing abilities after salvage TLM with proper training on modifications and compensations that minimize aspiration. Further study in a larger population is needed to substantiate this finding.
Although all patients communicated functionally with natural laryngeal voice after TLM, we observed below-normal postoperative speech scores (PSS-HN Understandability of Speech scores) in 3 of the 5 salvage cases. This finding was somewhat unexpected, because supraglottic laryngectomy spares the true vocal folds and is not traditionally associated with voice changes. 13 It is important to consider that the rating scale we used (PSS-HN subscale) provides a global assessment of speech intelligibility and may be affected by changes in voice, articulation, and/or resonance. As such, lower speech ratings in salvage cases likely resulted from factors beyond true vocal fold functioning that are commonly associated with radiotherapy, such as laryngeal edema, mucosal dryness, and decreased secretion management.
Rehabilitation efforts after salvage supraglottic TLM are prolonged by the concurrent effects of prior radiotherapy, as evidenced by the fact that the majority of our salvage patients were tube-dependent well beyond 1 year. The delayed functional recovery we observed is supported by a systematic review by Motamed et al 23 of the topic of salvage conservation laryngeal surgery. It is, therefore, imperative that individuals considering salvage supraglottic TLM be counseled appropriately to expect lengthy dysphagia rehabilitation, particularly when considering salvage resection of epiglottic tumors. Both of our salvage TLM patients with epiglottic tumors were tube-dependent for 2 years or more. This finding may be attributed to the larger defect that results from resection of an epiglottic tumor (compared with a false vocal fold tumor), coupled with baseline dysfunction from prior treatment. Despite a prolonged swallowing recovery, intelligible laryngeal voicing was preserved for all salvage TLM patients in this series. Thus, salvage supraglottic TLM may be an appropriate alternative for those individuals who prioritize more normal verbal communication over the faster swallowing recovery that is offered with salvage total laryngectomy.
In contrast, chronic dysphagia was not present in any of our patients who underwent TLM as primary treatment. Sensate aspiration was observed in only 3 of 5 cases in the first postoperative week, and resolution of aspiration was documented in all but 1 patient, who was unable to return for swallowing assessment after rehabilitation. The duration of tube dependency was also significantly shorter in previ-ously untreated cases; only 1 patient in this group (a 72-year-old man with mild chronic obstructive pulmonary disease) required enteral feedings for longer than 1 month. These findings are consistent with historical institutional data that found prolonged gastrostomy dependence in patients who required adjuvant radiotherapy (55 to 63 Gy) after open supraglottic laryngectomy. 6 Higher radiation doses and concurrent chemotherapy delivered during definitive radiotherapy likely further exacerbated the postsurgical dysphagia observed in salvage TLM cases in our study.
To date, comparisons of functional outcomes after TLM supraglottic laryngectomy have focused on outcomes relative to conventional open transcervical supraglottic laryngectomy. Although we acknowledge the limitations imposed by retrospective observational methods and a small sample size, we present a novel comparison of functional outcomes between frontline TLM and salvage TLM in patients with supraglottic carcinoma. It is notable that we found statistically significant distinctions in functional outcomes (higher aspiration rates and longer feeding tube dependence after salvage TLM) between the groups despite a limited sample size.
In addition, complete baseline data strengthen our ability to discern the discrete impact of prior cancer treatment on swallowing function. Baseline MBS studies confirmed that airway protection was substantially impaired in 4 of the 5 salvage cases before TLM. Similar tumor burdens were observed in previously untreated and salvage cases, but only salvage cases demonstrated impaired airway protection on baseline MBS studies. It is, therefore, our contention that these baseline impairments were likely related to the effects of prior radiotherapy and chemoradiotherapy. A review of 3 prospective clinical trials from the Radiation Oncology Treatment Group has underscored the long-term functional impairment of patients who undergo combined treatments. 24 Machtay et al 24 found that 43% of patients had some form of severe late toxicity, especially laryngopharyngeal dysfunction, requiring gastrostomy in 13%, and, less often, tracheostomy. This trend was particularly significant in patients with a primary tumor that arose in the larynx or hypopharynx, as opposed to the oral cavity or oropharynx (odds ratio, 4.17; p = 0.0041). When considered against the backdrop of modern multidisciplinary care of head and neck cancer, 24, 25 which often supports first treatment with radiation therapy, our experience and that of others suggest that TLM might provide patients added options for function-sparing treatment. Further research with a larger sample size is needed to confirm these preliminary observations. CONCLUSIONS Both local control and postoperative speech and swallow function after supraglottic TLM were better in previously untreated patients than in patients with salvage TLM after radiation or chemoradiation failure. Specifically, the prevalence of chronic aspiration and the duration of gastrostomy tube dependence were significantly greater after salvage TLM.
Within the two groups, those treated for false vocal fold primaries also demonstrated better functional outcomes than did those who had epiglottic primaries. These findings support the use of TLM as a primary treatment modality for selected patients with supraglottic carcinoma, providing the best chance for an optimal functional outcome. In the salvage surgical setting, TLM may also provide a chance for functional recovery, despite after-effects of radiotherapy in the laryngopharynx.
